Login / Signup

Shortening the Alzheimer's disease assessment scale cognitive subscale.

Stephen Z LevineYair GoldbergAnat RotsteinMyrto T SamaraKazufumi YoshidaAndrea CiprianiTakeshi IwatsuboStefan LeuchtToshiaki A Furawaka
Published in: European psychiatry : the journal of the Association of European Psychiatrists (2024)
IRT identified a short ADAS-cog version that separated donepezil and placebo, suggesting its clinical potential for assessment and treatment monitoring.
Keyphrases
  • cognitive decline
  • risk assessment
  • human health
  • study protocol
  • smoking cessation
  • open label
  • placebo controlled